Portside Wealth Group, LLC

Position in JNJ — Johnson & Johnson

CIK 1978608 Provo, UT

Position in JNJ

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$7,237,382

+$461,018 QoQ

Shares Held

28,497

+2.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.27%

of 13F equity value

Holder Rank

#1,321

of 4,663 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Portside Wealth Group, LLC holds $35,072,554 across 13 Drug Manufacturers - General names. JNJ ranks #1 (20.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	28,497	$7,237,382
2	LLY	ELI LILLY & Co	5,720	$6,860,739
3	ABBV	AbbVie Inc.	17,712	$4,457,047
4	NVO	Novo Nordisk A S	76,258	$3,655,808
5	MRK	Merck & Co., Inc.	21,032	$2,702,612
6	PFE	Pfizer Inc	89,045	$2,144,203
7	GILD	Gilead Sciences, Inc.	15,449	$1,951,826
8	NVS	Novartis AG	12,409	$1,944,738

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,237,382	28,497	+2.8%	Shares	Other	2026-07-14
2026-03-31	$6,776,364	27,722	-18.3%	Shares	Other	2026-05-12
2025-12-31	$7,025,537	33,948	+2.8%	Shares	Other	2026-01-21
2025-09-30	$6,122,938	33,022	+11.1%	Shares	Sole	2025-11-05
2025-06-30	$4,539,271	29,717	+0.7%	Shares	Other	2025-08-11
2025-03-31	$4,892,445	29,501	+96.8%	Shares	Sole	2025-04-14
2024-12-31	$2,167,564	14,988	+11.6%	Shares	Other	2025-04-14
2024-09-30	$2,176,302	13,429	+7.0%	Shares	Sole	2024-10-31
2024-06-30	$1,834,308	12,550	+6.3%	Shares	Other	2024-07-18
2024-03-31	$1,868,382	11,811	-1.4%	Shares	Other	2024-04-17
2023-12-31	$1,876,804	11,974	-13.1%	Shares	Other	2024-01-16
2023-09-30	$2,145,144	13,773	+8.8%	Shares	Other	2023-10-27
2023-06-30	$2,094,986	12,657	—	Shares	Other	2023-09-01
No filing history on record for this holder in this stock.